Current status of research on cognitive therapy/cognitive behavior therapy in Japan

Psychiatry and Clinical Neurosciences

Volumn 65, Issue 2, 2011, Pages 121-129

  Ono, Yutaka ^a   Furukawa, Toshi A ^b   Shimizu, Eiji ^c   Okamoto, Yasumasa ^d   Nakagawa, Akiko ^e   Fujisawa, Daisuke ^f   Nakagawa, Atsuo ^g   Ishii, Tomoko ^h   Nakajima, Satomi ⁱ  

^a KEIO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^g HIROSHIMA UNIVERSITY   (Japan)

^h KAWASAKI MEDICAL SCHOOL   (Japan)

ⁱ Takeda Clinic   (Japan)

Author keywords

cognitive behavior therapy; cognitive therapy; effectiveness; Japan

Indexed keywords

ACADEMIC ACHIEVEMENT; ANXIETY DISORDER; COGNITIVE THERAPY; DEPRESSION; HUMAN; JAPAN; MEDICAL RESEARCH; MENTAL HEALTH CARE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PROFESSIONAL COMPETENCE; REVIEW; SOCIAL PHOBIA;

CLINICAL TRIALS AS TOPIC; COGNITIVE THERAPY; HUMANS; JAPAN; MENTAL DISORDERS;

EID: 79952962434     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2010.02182.x     Document Type: Review

References (40)

1. Fujisawa D, Nakagawa A, Sado M, et al,. Current Status and Dissemination of Psychotherapies in Japan. Japan Ministry of Health and Labor, Tokyo, 2006.
2. Fujisawa D, Nakagawa A, Tajima M, et al,. Cognitive behavioral therapy for depression among adults in Japanese clinical settings: A single-group study. BMC Res. Notes 2010; 7: 160.
3. Yoshimura S, Ueda K, Suzuki SI, et al,. Self-referential processing of negative stimuli within the ventral anterior cingulate gyrus and right amygdala. Brain Cogn. 2009; 69: 218-225.
4. Onoda K, Okamoto Y, Nakashima K, et al,. Decreased ventral anterior cingulate cortex activity is associated with reduced social pain during emotional support. Soc. Neurosci. 2009; 4: 443-454.
5. Yoshimura S, Okamoto Y, Onoda K, et al,. Rostral anterior cingulate cortex activity mediates the relationship between the depressive symptoms and the medial prefrontal cortex activity. J. Affect. Disord. 2010; 122: 76-85.
6. Okamoto Y,. Functional brain basis of pathophysiology in depression. Seishin Shinkeigaku Zasshi 2009; 111: 1330-1344 (in Japanese).
7. Matsunaga M, Okamoto Y, Suzuki SI, et al,. Psychosocial functioning in patients with treatment-resistant depression after group cognitive behavioral therapy. BMC Psychiatry 2010; 10: 22.
8. Watanabe N, Furukawa TA, Shimodera S, et al,. Brief behavioral therapy for refractory insomnia in residual depression: Assessor-blind, randomized controlled trial. J. Clin. Psychiatry (in press).
9. Kobayashi K, Shimizu E, Hashimoto K, et al,. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: As a biological predictor of response to group cognitive behavioral therapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29: 658-663. (Pubitemid 40897773)
10. Sakai Y, Kumano H, Nishikawa M, et al,. Changes in cerebral glucose utilization in patients with panic disorder treated with cognitive-behavioral therapy. Neuroimage 2006; 33: 218-226. (Pubitemid 44397589)
11. Nakano Y, Lee K, Noda Y, et al,. Cognitive-behavior therapy for Japanese patients with panic disorder: Acute phase and one-year follow-up results. Psychiatry Clin. Neurosci. 2008; 62: 313-321. (Pubitemid 351832307)
12. Wade WA, Treat TA, Stuart GL,. Transporting an empirically supported treatment for panic disorder to a severe clinic setting: A benchmarking strategy. J. Consult. Clin. Psychol. 1998; 66: 231-239. (Pubitemid 28208305)
13. Martinsen EW, Olsen T, Tonset E, et al,. Cognitive-behavioral group therapy for panic disorder in the general clinical setting: A naturalistic study with 1-year follow-up. J. Clin. Psychiatry 1998; 59: 437-442. (Pubitemid 28391571)
14. Hahlweg K, Fiegenbaum W, Frank M, et al,. Short- and long-term effectiveness of an empirically supported treatment for agoraphobia. J. Consult. Clin. Psychol. 2001; 69: 375-382. (Pubitemid 32667020)
15. Barlow DH, Gorman JM, Shear MK, et al,. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial. JAMA 2000; 283: 2529-2536. (Pubitemid 30324195)
16. Perini SJ, Slade T, Andrews A,. Generic effectiveness measures: Sensitivity to symptom change in anxiety disorders. J. Affect. Disord. 2006; 90: 123-130. (Pubitemid 43183520)
17. Furukawa TA, Watanabe N, Churchill R,. Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review. Br. J. Psychiatry 2006; 188: 305-312.
18. Furukawa T, Watanabe N, Churchill R,. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst. Rev. 2007; (1): CD004364.
19. Furukawa TA, Watanabe N, Omori IM,. Can pill placebo augment cognitive-behavior therapy for panic disorder? BMC Psychiatry 2007; 7: 73.
20. Lee K, Noda Y, Nakano Y, et al,. Interoceptive hypersensitivity and interoceptive exposure in patients with panic disorder: Specificity and effectiveness. BMC Psychiatry 2006; 6: 32.
21. Noda Y, Nakano Y, Lee K, et al,. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder. BMC Psychiatry 2007; 7: 70.
22. Ogawa S, Furukawa TA, Nakano Y, et al,. Interoceptive hypersensitivity as prognostic factor among patients with panic disorder who have received cognitive behavioral therapy. J. Behav. Ther. Exp. Psychiatry 2010; 41: 325-329.
23. Watanabe N, Churchill R, Furukawa TA,. Combination of psychotherapy and benzodiazepines versus either therapy alone for panic disorder: A systematic review. BMC Psychiatry 2007; 7: 18.
24. Watanabe N, Churchill R, Furukawa TA,. Combined psychotherapy plus benzodiazepines for panic disorder. Cochrane Database Syst. Rev. 2009; (1): CD005335.
25. Chen J, Nakano Y, Ietzugu T, et al,. Group cognitive behavior therapy for Japanese patients with social anxiety disorder: Preliminary outcomes and their predictors. BMC Psychiatry 2007; 7: 69.
26. Furukawa TA, Chen J, Watanabe N, et al,. Videotaped experiments to drop safety behaviors and self-focused attention for patients with social anxiety disorder: Do they change subjective and objective evaluations of anxiety and performance? J. Behav. Ther. Exp. Psychiatry 2009; 40: 202-210.
27. Chen J, Furukawa TA, Nakano Y, et al,. Video feedback with peer ratings in naturalistic anxiety-provoking situations for social anxiety disorder: Preliminary report. J. Behav. Ther. Exp. Psychiatry 2010; 41: 6-10.
28. Heimberg RG, Liebowitz MR, Hope DA, et al,. Cognitive behavioral group therapy for social phobia: 12-week outcome. Arch. Gen. Psychiatry 1998; 55: 1133-1141. (Pubitemid 28558287)
29. Stangier U, Hedenreich T, Peitz M, et al,. Cognitive therapy for social phobia: Individual versus group treatment. Behav. Res. Ther. 2003; 41: 991-1007. (Pubitemid 36952355)
30. Mortberg E, Clark DM, Sundin O, et al,. Intensive group cognitive treatment and individual cognitive therapy vs. treatment as usual in social phobia: A randomized controlled trial. Acta Psychiatr. Scand. 2007; 115: 142-154. (Pubitemid 46114875)
31. Nakatani E, Nakagawa A, Nakao T, et al,. A randomized controlled trial of Japanese patients with obsessive-compulsive disorder: Effectiveness of behavior therapy and fluvoxamine. Psychother. Psychosom. 2005; 74: 269-276. (Pubitemid 41160197)
32. Nakatani E, Nakagawa A,. Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder. Psychother. Psychosom. 2008; 77: 393-394.
33. Okajima M, Hashimoto K, Noguchi Y, et al,. Treatment outcome of obsessive compulsive disorder. Seishinka-Chiryogaku 2007; 22: 509-516 (in Japanese).
34. Yamamoto M, Iikura Y, Miyakawa A,. Research of inpatients with obsessive-compulsive symptom regarding reasons for hospitalization, applied treatment methods, and treatment effects. Seishin-Igaku 2006; 48: 391-398 (in Japanese).
35. Yoshida H, Konishi T, Kamo T,. Trial of prolonged exposure therapy for chronic post traumatic stress disorder in Japan. Jpn. J. Gen. Hosp. Psychiatry 2008; 20: 55-62 (Abstract, in English).
36. Asukai N, Saito A, Tsuruta N, et al,. Pilot study on prolonged exposure of Japanese patients with posttraumatic stress disorder due to mixed traumatic events. J. Trauma. Stress 2008; 21: 340-343. (Pubitemid 351962002)
37. Foa EB, Hembree EA, Cahill SP, et al,. Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: Outcome at academic and community clinics. J. Consult. Clin. Psychol. 2005; 73: 953-964. (Pubitemid 41643245)
38. Schnurr PP, Friedman MJ, Engel CC, et al,. Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial. JAMA 2007; 297: 820-830. (Pubitemid 46333947)
39. Ishii T, Ono Y, Takeda R, et al,. Trial of dialectical behaviour therapy for borderline personality disorder in Japan. Jpn. J. Cogn. Ther. 2009; 2: 42-44 (in Japanese).
40. Ishii T,. Dialectical behaviour therapy for borderline personality disorder in Japan. Kokoro rinsho, a rakaruto 2007; 26: 599-603 (in Japanese).